Ready to revolutionize your R&D processes with our Organoid-on-Plate technology?
Contact us today to discuss your needs.
Transforming pharma & biotech R&D with advanced organoid solutions
Our organoid-on-plate tactical roadmap is designed to transform pharmaceutical, biotechnological, and diagnostic applications.
By developing automated and standardized solutions, we enhance the production, sorting, positioning, maturation, and analysis of organoid technology integral to drug discovery, tissue engineering, and diagnostic procedures.
Automated microphysiological systems and organ-on-chip are developed for complex 3D models on plate and chip from design to biovalidation. The complex 3D models range from spheroids, microtissues, organoids, tumor organoids, assembloids to cuboids.
Our innovative approach integrates advanced organoid technologies with R&D processes, paving the way for accelerated drug discovery and development in the pharmaceutical and biotechnological sectors.
Microfluidics: Precision control and manipulation of fluids at the microscopic scale
Bioreactors: Promoting cell culture growth and tissue engineering
Environment control: Optimizing conditions for effective cellular function and growth.
Comprehensive design: Solutions tailored to your specific research requirements
Diverse range: Including inserts, chips, plates, lids – all manufactured to meet the highest industry standards
Inclusive of organoids, spheroids, and microtissues
Robust biovalidation of technologies for superior performance and reliability
Want to read more on this topic? Click on the related articles below or download our extensive list of Tools for Life Science flyers:
Complex 3D cell models are revolutionizing personalized medicine in drug testing and tissue engineering. Implementing these mini-organs in the applied research and industrial landscape requires new tools for process standardization and parallelization. HistoBrick is a new tool that paves the way toward high-throughput and standardized micro-histology.
INVENesis teamed up with INRAE and CSEM to develop a novel testing system for developing antiparasitic treatments. Several leading animal-health businesses have already expressed an interest in the technology. The new invention comes at a critical time, since a growing number of parasites are becoming resistant to existing drugs.
Development of a disruptive solution that enables the 3D printing of tissue-engineered constructs. Coordinated by CSEM, eight consortium members will create a standardized and automated tissue preparation and maturation platform, which will provide patients with End-Stage Liver Disease (ESLD) an alternative to donor organ transplants.
Industrialized with CSEM technological support, Gri3D™ enables the large-scale, standardized, rapid, and reliable production of 3-D in vitro organoid cultures from patient stem cells. This groundbreaking, large scale standardizing of organoids represents a key advancement toward truly personalizing medicine.
Contact us today to discuss your needs.